Sign In
Buy HSIC
$75.74
-0.300 (-0.395%)
At Close: Jun 03, 2026
Henry Schein Provides Update on CEO Search Process
04:05pm, Tuesday, 23'rd Dec 2025
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world's largest provider of health care solutions to office-based dental and medical practitioners, today an
Stock Futures Cool Off After Delayed GDP Data
09:14am, Tuesday, 23'rd Dec 2025
Stock futures are quietly lower as investors unpack previously delayed GDP data for the third quarter
McKesson (NYSE:MCK) vs. Henry Schein (NASDAQ:HSIC) Critical Analysis
01:58am, Wednesday, 17'th Dec 2025
Henry Schein (NASDAQ: HSIC - Get Free Report) and McKesson (NYSE: MCK - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the
Arrowstreet Capital Limited Partnership Has $21.12 Million Holdings in Henry Schein, Inc. $HSIC
03:24am, Monday, 08'th Dec 2025
Arrowstreet Capital Limited Partnership grew its stake in Henry Schein, Inc. (NASDAQ: HSIC) by 80.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Excha
Henry Schein Can Make Your Portfolio Smile
02:53pm, Friday, 05'th Dec 2025
Henry Schein stands out as the largest global provider of healthcare products and services for office-based dental and medical practitioners, with a strong market share. HSIC continues to deliver soli
Why Is Henry Schein (HSIC) Up 1.2% Since Last Earnings Report?
12:37pm, Thursday, 04'th Dec 2025
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
01:13pm, Tuesday, 02'nd Dec 2025
Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
HSIC Stock Benefits From Expanded Partnership With vVARDIS
09:26am, Tuesday, 02'nd Dec 2025
Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.
Henry Schein Expands Partnership with vVARDIS
04:34pm, Monday, 01'st Dec 2025
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the dril
HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch
08:56am, Monday, 01'st Dec 2025
HSIC gains momentum as Henry Schein One rolls out AI-powered dental workflows unveiled at the Greater New York Dental Meeting.
Artisan Select Equity Fund Q3 2025 Portfolio Review
05:04am, Thursday, 27'th Nov 2025
Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung
Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting
06:30am, Tuesday, 25'th Nov 2025
AMERICAN FORK, Utah--(BUSINESS WIRE)--Coming off the heels of its announcement with Amazon Web Services, Henry Schein One, the leading provider of global dental technology, today unveils natively embe
American Century Mid Cap Value Fund Q3 2025 Contributors/Detractors And Notable Trades
12:55pm, Thursday, 20'th Nov 2025
Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. Shares of Henry Schein declined as p
Henry Schein, Inc. (HSIC) Presents at Jefferies London Healthcare Conference 2025 Transcript
11:58am, Tuesday, 18'th Nov 2025
Henry Schein, Inc. ( HSIC ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Stanley Bergman - Executive Chairman & CEO Andrea Albertini - Chief Executive
Mario Cibelli's Strategic Moves: A Closer Look at Remitly Global Inc's Impact
07:03am, Friday, 14'th Nov 2025
Insights from the Third Quarter 2025 13F Filing Mario Cibelli (Trades, Portfolio), a seasoned investor and founder of Marathon Partners Equity Management, rece
